Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1979 Jun 9;1(6177):1530–1533. doi: 10.1136/bmj.1.6177.1530

Unknown primary adenocarcinoma: incidence of overinvestigation and natural history.

J F Stewart, M H Tattersall, R L Woods, R M Fox
PMCID: PMC1599694  PMID: 466103

Abstract

Out of 1300 patients referred to a medical oncology unit, there were 87 with metastatic cancer in whom a primary tumour site was not evident from the history and after physical examination and chest radiography had been carried out. An analysis of the investigations performed in these patients and their results showed that in only eight of the 87 patients did non-surgical investigations at presentation determine the primary site. In two patients it was identified by diagnostic laparotomy, and in a further 13 clinical follow-up led to recognition of the primary tumour site before death. Few investigations should be performed in patients in whom the primary site is known since they have a low yield, and in our population identifying the primary tumour did not improve the outcome or alter management. Treatable tumours should be excluded, and this may be done in most cases by simple blood tests, particularly those measuring acid phosphatase activity and other tumour markers.

Full text

PDF
1530

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Didolkar M. S., Fanous N., Elias E. G., Moore R. H. Metastatic carcinomas from occult primary tumors. A study of 254 patients. Ann Surg. 1977 Nov;186(5):625–630. doi: 10.1097/00000658-197711000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Golomb H. M., Thomsen S. Estrogen receptor. Therapeutic guide in undifferentiated metastatic carcinoma in women. Arch Intern Med. 1975 Jul;135(7):942–945. doi: 10.1001/archinte.135.7.942. [DOI] [PubMed] [Google Scholar]
  3. Kiang D. T., Kennedy B. J. Estrogen receptor assay in the differential diagnosis of adenocarcinomas. JAMA. 1977 Jul 4;238(1):32–34. [PubMed] [Google Scholar]
  4. Moertel C. G., Reitemeier R. J., Schutt A. J., Hahn R. G. Treatment of the patient with adenocarcinoma of unknown origin. Cancer. 1972 Dec;30(6):1469–1472. doi: 10.1002/1097-0142(197212)30:6<1469::aid-cncr2820300609>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  5. Nystrom J. S., Weiner J. M., Heffelfinger-Juttner J., Irwin L. E., Bateman J. R., Wolf R. M. Metastatic and histologic presentations in unknown primary cancer. Semin Oncol. 1977 Mar;4(1):53–58. [PubMed] [Google Scholar]
  6. Osteen R. T., Kopf G., Wilson R. E. In pursuit of the unknown primary. Am J Surg. 1978 Apr;135(4):494–497. doi: 10.1016/0002-9610(78)90026-0. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES